SpringerProtocols: Abstract: Anti-MDR1 Ribozyme Gene Therapy

Anti-MDR1 Ribozyme Gene Therapy

By: Takao Ohnuma², Hiroyuki Kobayashi², Fu-Sheng Wang³

Abstract

Full Text

Download PDF (218K)

Multidrug resistance (MDR) in human cancer seriously limits the efficacy of anticancer agents. Circumvention of MDR is, thus, one of the urgent goals for successful cancer chemotherapy.

Affiliation(s): (2) Division of Neoplastic Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, NY
(3) Department of Medicine, Division of Neoplastic Diseases, Mount Sinai School of Medicine, New York, NY

Book Title: Gene Therapy of Cancer: Methods and Protocols

Series: Methods in Molecular Medicine | Volume: 35 | Pub. Date: Feb-17-2000 | Page Range: 207-245 | DOI: 10.1385/1-59259-086-1:207

Subject: Cancer Research

References

Download References

1.	Germann, U. A. and Harding, M. W. (1995) Chemosensitizers to overcome and prevent multidrug resistance? J. Natl. Cancer Inst. 87, 1573–1575.

2.	Gottesman, M. M., Pastan, I., and Ambudkar, S. V. (1996) P-glycoprotein and multidrug resistance. Current. Opin. Genet. Dev. 6, 610–617.

3.	Ling, V. (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40 (Suppl. 1), S3–S6.

4.	Bellamy, W. T. (1996) P-glycoproteins and multidrug resistance. Ann. Rev. Pharmacol. Toxicol. 36, 161–183

5.	Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S-L., Gazdar, A., et al. (1989) Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116–124.

6.	Trock, B. J., Leonessa, F., and Clark, R. (1997) Multidrug resistance in breast cancer: a meta analysis. J. Nat. Cancer Inst. 89, 917–931.

7.	Bradley, G. and Ling. V. (1994) P-glycoprotein multidrug resistance and tumor progression. Cancer Metastasis Rev. 132, 223–233.

8.	Marie, J-P. (1995) P-glycoprotein in adult hematologic malignancies. Hematol. Oncol. Clin. North Am. 9, 239–249.

9.	Georges, E., Sharom, F. J., and Ling, V. (1990) Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv. Pharmacol. 21, 185–220.

10.	Fuqua, S. A. W., Moretti-Rojas, I. M., Schneider, S. L., and McGuire, W. L. (1987) P-glycoprotein expression in human breast cancer cells. Cancer Res. 47, 2103–2106.

11.	Lemontt, J. F., Azzaria, M., and Gros, P. (1988) Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells. Cancer Res. 48, 6348–6353,.

12.	Li, X. K., Kobayashi, H., Holland, J. F., and Ohnuma, T. (l993) Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines. Leukemia Res. 17, 483–490.

13.	Cech, T. R. (1988) Ribozymes and their medical implications. J. A. M. A. 260, 3030–3034.

14.	Haseloff, J. and Gerlach, W. J. (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585–591.

15.	Kobayashi, H., Dorai, T., Holland, J. F., and Ohnuma T. (1994) Reversal of drug sensitivity in multidrug-resistant tumor cells by MDR1 (PGY1) ribozyme. Cancer Res. 54, 1271–1275.

16.	Masuda, Y., Kobayashi, H., Holland, J. F., and Ohnuma, T. (1998) Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex. Cancer Chemother. Pharmacol. 42, 9–16.

17.	Kobayashi, H., Takemura, Y., Wang, F-S., Oka, T., and Ohnuma, T. (1999) Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: Screening for effective target sites. Int. J. Cancer 81, 944–950.

18.	Wang, F-S., Kobayashi, H., Liang, K-W., Holland, J. F., and Ohnuma, T. (1999) Retrovirus-mediated anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells. Human Gene Therapy 10, 1185–1195.

19.	Kiehntopf, M., Brach, M. A., Licht, T., Petschauer, S., Karawajew, L., Kirschning, C., and Herrmann, F. (1994) Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13, 4645–4652.

20.	Sullivan, S. M. (1994) Development of ribozymes for gene therapy. J. Invest. Dermatol. 103, 85S–89S.

21.	Paolella, G., Sproat, B. S., and Lamond, A. I. (1992) Nuclease resistant ribozymes with high catalytic activity. EMBO J. 11, 1913–1919.

22.	Gunning, P., Leavitt, J., Muscat, G., Ng, S-Y., and Kedes, L. (1987) A human p-actin expression vector system directs high-level accumulation of antisense transcript. Proc. Natl. Acad. Sci. USA 84, 4831–4835.

23.	Adeniyi-Jones, S., Romeo, P. H., and Zasloff, M. (1984) Generation of long read-through transcripts in vivo and in vitro by deletion of 3′ termination and processing sequences in the human tRNAi^met gene. Nucleic Acids Res. 12, 1101–1115.

24.	Hantzopoulos, P. A., Sullenger, B. A., Ungers, G., and Gilboa, E, (1989) Improved gene expression upon transfer of the adenosine deaminase minigene outside of the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. 86, 3519–3523.

25.	Minowada, J., Ohnuma, T., and Moore, G. E. (1972) Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49, 891–895.

26.	Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H., and Clifford, P. (1968) Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 28, 1300–1310.

27.	Cowan, K. H., Batist, G., Tulpule, A., Sinha, B., and Myers, C. E. (1986) Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. USA 83, 9328–9332.

28.	Jainchill, J. L., Aaronson, S. A., and Todaro, G. J. (1969) Murine sarcoma and leukemia viruses: assay using clonal line of contact-inhibited mouse cells. J. Virol. 4, 549–553.

29.	Markowitz, D., Goff, S., and Bank, A. (1988) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400–406.

30.	Milligan, J. F., Groebe, D., R., Witherell, G. W., and Uhlenbeck, O. C. (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucl. Acids Res. 15, 8783–8798.

31.	Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., and Willingham, M. C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. USA 85, 4486–4490.

32.	Riordan, J. R. and Ling, V. (1974) Purification of p-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced permeability. J. Biol. Chem. 254, 12701–12705.

33.	Fairbanks, G., Steck, T. C., and Wallach, D. F. H. (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10, 2602–2617.

34.	Hamada, H. and Tsuruo, T. (1986) Functional role for the 170-and 180-kDa glycoprotein specific to drug resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 83, 7785–7789.

35.	Chen, C. J., Chin, J. E., Ueda, K., Clark, D., Ueda, K., Pastan, I., et al.(1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381–389.

36.	Kain, K. C., Orlandi, P. A., and Lanar, D. E. (1991) Universal promoter for gene expression without cloning: expression-PCR. Biotechniques 10, 366–373.

37.	Takigawa, N., Danno, K., and Furukawa, F. (1987) Effects of colchicine and cytochalasin B on distribution of concanavalin A receptors in isolated and cultured guinea pig epidermal cells. Arch. Dermatol. Res. 279, 392–397.

38.	Finbloom, D. S., Martin, J., and Gordon, R. K. (1987) Endocytosis of particulate and soluble IgG immune complexes: differential effects of cytoskeletal modulating agents. Clin. Exp. Immunol. 67, 205–210.

Comments (Loading...)

Post comment/View all comments